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A B S T R A C T
The steroidogenic enzyme P450 aromatase (ARO) has a key role in the conversion of testosterone
(T) into estrogens (E), expressed as 17β-estradiol. The presence and localization of this key en-
zyme have not been described before in the South American camelid alpaca (Vicugna pacos). In
our previous studies of the expression and biological eﬀects of orexin A (OxA) and OxB on the
alpaca testis demonstrated that OxA, via its speciﬁc receptor 1 (OX1R), stimulated T synthesis. In
order to extend these ﬁndings, we presently explored the presence and localization of ARO in the
alpaca male gonad, and the possible correlation between ARO and the orexinergic complex.
Western blotting and immunohistochemistry demonstrated the presence of ARO in tissue
homogenates and its localization in the tubular and interstitial compartments of the alpaca testis,
respectively. The addition of OxA to fresh testicular slices decreased the 17β-estradiol E levels.
This eﬀect was annulled by the sequential addition of the selective OX1R antagonist, SB-408124.
OxB incubation did not have any eﬀect on the biosynthesis of E. Furthermore, the OxA-mediated
down-regulation of E secretion could be ascribed to ARO inhibition by exogenous OxA, as in-
dicated by measurement of ARO activity in tissue slices incubated with OxA. Overall, our ﬁndings
suggest that locally secreted OxA interacting with OX1R could indirectly inhibit ARO activity,
disabling the conversion of T to E, and consequently lowering E biosynthesis and increasing the
production of T in mammalian testis.
1. Introduction
In the male gonad, sexual steroids occupy a central role in spermatogenesis and steroidogenesis regulation. Testosterone (T)
secreted by the interstitial (Leydig) cells is critical for several reproductive functions (McLachlan et al., 1996). In mammals, also
estrogens (E) are involved in several testicular phenomena (Hess et al., 1997, Hess and Carnes, 2004; O’Donnell et al., 2001; Carreau
et al., 2007; O’Donnell et al., 2001). The biosynthesis of E is catalyzed by the irreversible aromatization of androgens by P450
aromatase (ARO) (Carreau, 2003; O’Donnell et al., 2001; Carreau et al., 2007, 2011). ARO is an enzymatic complex encoded by the
CYP19A1 gene and is characterized by two proteins: a ubiquitous NADPH-cytochrome P450 reductase and a cytochrome P450
aromatase (Carreau et al., 2011). ARO is localized in the cellular endoplasmic reticulum in diﬀerent body districts and in the male
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gonad (Carreau et al., 2001). The presence of ARO in the testes has been described in numerous species (Menad et al., 2017; Carreau
et al., 2006, 2011; Carpino et al., 2001; Nitta et al., 1993; Levallet et al., 1998).
Orexin A (OxA) and OxB are two peptides of hypothalamic origin, derived from the proteolytic cleavage of a common precursor
called prepro-orexin (Sakurai et al., 1998; de Lecea et al., 1998). The biological eﬀects of these peptides are mediated by binding with
two G coupled receptors called orexin 1 (OX1R) and OX2R for orexins. OX1R ﬁrst is speciﬁc for OxA, while OX2R can bind the two
peptides with equal aﬃnity. In the male genital apparatus, prepro-orexin, OxA, and OX1R were investigated in the testis and epi-
didymis of rat (Barreiro et al., 2004, 2005; Assisi et al., 2012; Tafuri et al., 2009, 2010), alpaca (Vicugna pacos) (Liguori et al., 2012,
2014), mouse testis (Joshi and Singh, 2016, 2017), the urethro-prostatic complex of cattle (Russo et al., 2008), and in the normal,
hyperplastic and neoplastic prostate of human beings (Alexandre et al., 2014; Valiante et al., 2013, 2015). Moreover, OxB and OX2R
distribution were described in the testis of rat (Liguori et al., 2017a) and alpaca (Liguori et al., 2017b), and OX2R mRNAs were
detected in several male genital organs (Karteris et al., 2004) and prostate (Malendowicz et al., 2011) of humans.
Alpaca is a South American camelid that is phylogenetically comparable to llama (Lama glama) and guanaco (Lama guanicoe). The
breeding of alpaca has always been important in the Andean culture for their wool and meat, and currently, has spread to Europe,
including Italy. Alpacas have adapted to survive in the high-altitude Andean regions, and when transferred in more temperate
climates, became more fertile because of optimal nutrition for the majority of the year (Fowler, 1998).
The main aim of this study was to provide the ﬁrst evidence of ARO in the alpaca testis and the eﬀects of orexins on this enzyme
and E biosynthesis (expressed as 17β- estradiol). For this purpose, we investigated the presence and localization of ARO in the alpaca
testis by means of western blotting and immunohistochemical analyses, respectively. Furthermore, we explored the relationship
between orexins and ARO, focusing our attention on 17β- estradiol synthesis in vitro experimentally and on cultured testicular slices.
Considering the previous demonstration of the eﬀect of OxA on T production in alpaca testis (Liguori et al., 2012), we presently
addressed whether this eﬀect also involved E biosynthesis and/or ARO modulation.
2. Material and methods
2.1. Antibodies and chemicals
The OxA (003-30) and OxB (003-32) peptides were obtained from Phoenix Pharmaceuticals Inc. (Karlsruhe, Germany). The OX1R
antagonist, SB-408124, luteinizing hormone (LH) from sheep pituitary (L5269), and bovine serum albumin (BSA) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). The estradiol ELISA kit (DKO003) was purchased from Diametra (Perugia, Italy). Rabbit
polyclonal anti-cytochrome P450 (aromatase) antibody (ABIN3023082) was purchased from Antibodies-online.com. Biotinylated
goat anti-rabbit (BA-1000) secondary antibody and VECTASTAIN ABC kit (PK-6105) and 3,3′-diaminobenzidine tetra-hydrochloride
(DAB) solution were from Vector Laboratories (Burlingame, CA, USA). Qproteome Formalin-Fixed Paraﬃn-embedded (FFPE) Tissue
Kit was purchased from Qiagen (Hilden, Germany). Peroxidase-AﬃniPure goat anti-rabbit IgG secondary antibody (111-035-003)
was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). The DC protein assay kit from Bio-Rad
Laboratories (Hercules, CA, USA). Enhanced chemiluminescence (ECL, Western Bright ECL) was purchased from Advansta, (Menlo
Park, CA, USA). The marker proteins were from Prosieve QuaColor (London, UK).
2.2. Animals and tissue collection
The animals for this work were kept in sanitary, nutritional, and semi-ranged environments at the “Domus Alpaca” farm (Pratola
Peligna, Italy). Five healthy sexually matured males with no preputial adhesions detected underwent orchiectomy as previously
described (Fowler, 1998). The protocol followed the International Guiding Principles for Biomedical Research Involving Animals in
Italy and were approved by Italian laws (D. Lgs 26/2014). Animal care was guaranteed during the surgical procedures and the
experimental research was approved by the Ethical Animal Care and Use Committee of the University of Naples Federico II, De-
partment of Veterinary Medicine and Animal Production, Naples, Italy (no. 0024889). The owner of the animals gave verbal consent
to perform surgical procedures, collection of the samples and animals were not involved in any clinical trials or treatments. Im-
mediately after the orchiectomy procedure, testis samples were carefully cut into small pieces and rapidly ﬁxed in Bouin’s ﬂuid for
FFPE western blotting and immunohistochemical techniques as previously described (Liguori et al., 2013). Other samples for in vitro
experiments were frozen at -80 °C.
2.3. Protein extraction and Western blotting analysis
The Qproteome FFPE Tissue Kit was used for protein extraction from sections obtained by cutting paraﬃn-embedded SSS samples
(Becker et al., 2007). Sections 15 μm in thickness were deparaﬃnized in xylene and rehydrated in a series of descending alcohol
solutions. Then, 100 μL of extraction buﬀer (EXB) along with β-mercaptoethanol and 1x protease and phosphatase inhibitor cocktail
were added to the hydrated material. After cooling on ice for 5min, samples were heated at 100 °C for 20min and successively at
80 °C for 2 h with continuous shaking. Total proteins were recovered after centrifugation at 14,000 × g at 4 °C for 15min, and their
concentration was determined by the Bradford protein assay using bovine serum albumin (BSA) as the standard. Western blotting was
performed as described elsewhere (Pelagalli et al., 2016; D’Angelo et al., 2016). Nitrocellulose membranes were probed overnight at
4 °C with anti-ARO antibody (diluted 1:400 in 2.5% BSA), washed three times in Tris-buﬀered saline containing Tween 20 (TBS-T)
and incubated with peroxidase-aﬃniPure goat anti-rabbit IgG antibody (diluted 1:5000 in 2.5% BSA) for 1 h. Then, the membranes
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were treated with ECL and the obtained signals were detected using a C-Digit blot scanner (LI-COR Biosciences, Lincoln, NB, USA).
Prosieve QuadColor proteins were used as the standard.
2.4. Immunohistochemistry
After Bouin’s ﬂuid ﬁxation, the specimens were dehydrated in a series of ascending alcohols and embedded in Paraplast.
Successive 7 μm-thick sections were obtained. After deparaﬃnization and hydration procedures, the sections were immersed in citric
buﬀer (pH 6.0) and antigen retrieval was performed (Arcamone et al., 2014). Tissue sections were stained with the ABC method as
described elsewhere (De Luca et al., 2014; Liguori et al., 2015). Sections were covered with DAB solution until the desired intensity of
staining was achieved and then were counterstained with hematoxylin to better identify the correct cytotypes. The slides were
observed using a model DMRA2 microscope (Leica, Wetzlar, Germany). Negative controls were obtained by omitting the primary
antiserum used.
2.5. In vitro Test for 17β- estradiol determination
Testis samples were de-capsulated, cut into small pieces (250mg each) and distributed into sample tubes (one piece per tube).
After addition of 2mL of KRB buﬀer (10mM glucose, 100 μM bacitracin, 0.1% ascorbic acid, and 0.1% BSA), the tubes were
incubated for 60min at 37 °C in 95% O2 and 5% CO2 with shaking at 60 cycles/min. The medium was then substituted with 2mL of
fresh KRB buﬀer and 1 nM of each substance, depending on the group. The ﬁrst group was the control incubated with KRB buﬀer
alone. In the second group, LH was added to verify tissue vitality. In the third group, OxA was added. In the fourth group, OxA was
added followed by the OX1R antagonist, SB-408124. The last group included only OxB. All sample tubes were incubated at 37 °C for
12 h. After incubation, ethyl ether was added to each sample and shaken vigorously. The samples were stored at −18 °C for 10min
and the supernatants were collected. These supernatant-containing tubes were dried overnight at room temperature. The residue in
each tube was dissolved in 0.5mL of 0.05M sodium phosphate buﬀer, pH 7.5, containing 10mg/mL BSA. The 17β-estradiol level was
determined by the 17β-estradiol ELISA kit according to the manufacturer instructions. The experiments were performed in triplicate
and the limits of detection were identiﬁed; the sensitivity, intra-assay variability, and inter-assay variability were 4 pg, 4.9%, and
6.8%, respectively. The rate of E recovery from the male gonad corresponded to 85%.
2.6. ARO activity assay
ARO activity was measured by evaluating the in vitro conversion rate of T to 17β-estradiol in fresh tissue. Testicular slices were
distributed in each well of a multi-well plate and the aforementioned substances were added. Finally, each well was incubated with T
(35 μM) dissolved in 100 μmL of NADPH solution (3mg/mL). The suspensions were incubated in a shaking bath as described above
and then rapidly frozen. The well contents were extracted three times with ether. Solvents were pooled and dried in air. 17β-Estradiol
determination was carried out on the residues using the enzyme-linked immunoassay (ELISA) kits as previously reported. The results
are expressed as the 17β-estradiol concentration produced per g of tissue and per h.
2.7. Statistical analyses
The results obtained in the in vitro experiments were statistically processed by Duncan’s test for multi-group comparison and
Student’s t-test for between-group comparison. All statistical results were deﬁned as mean ± S.D. (standard deviation). A P-
value<0.01 and P < 0.05 were indicative of signiﬁcance depending on the experiment.
3. Results
3.1. Expression of ARO in tissue homogenates
Western blot analysis using a rabbit polyclonal P450 ARO antibody revealed a positive signal having a molecular mass of
55–60 kDa in protein extracted from alpaca testis (Fig. 1, lane 1). These data were conﬁrmed in rat testis, used as a positive control.
Fig. 1. ARO expression in tissue extracts. Western blotting of ARO production in testis from alpaca (lane 1) and rat (lane 2; positive control). A
speciﬁc band was observed at 51 kDa by comparison with co-migrating size markers. Western blot analysis was performed using anti-CYP19 (P450
ARO) antibody. Representative data from three independent experiments are shown.
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3.2. Immunohistochemical detection of ARO in alpaca testis
Analysis of tissue sections showed the presence of ARO- immunoreactivity (IR) in Leydig (Fig. 2a) and Sertoli (Fig. 2b) cells, oval
spermatogonia (Fig. 2c), in resting or preleptotene (Fig. 2d) and pachytene (Fig. 2e) spermatocytes and in round (immature) sper-
matids (Fig. 2f). Positive Leydig cells (Fig.2a) were intensely stained and the cytoplasm was almost completely ﬁlled by im-
munoreactive granules that were sometimes condensed. Few positive supporting (Sertoli) cells (Fig. 2b) were characterized by the
immunoreactive material describing the entire proﬁle of these cytotypes. In oval spermatogonia (Fig. 2c) and resting spermatocytes
(Fig. 2d), the reactive granules clustered largely in one extremity of the cytoplasm. Couples of positive resting spermatocytes ori-
ginating from the spermatogonia division were often described in this species (Fig. 2d). In pachytene spermatocytes, the positive
material was described as a single roundish cytoplasmic granule close to the nuclear membrane of the cells. Only round (immature)
Fig. 2. ARO-IR in cytotypes of alpaca testis. (a): Large group of Leydig cells containing immunoreactive material in their cytoplasm. (b) immuno-
positive material entirely ﬁlled the cytoplasm of a few Sertoli cells, deﬁning their proﬁle from the basal membrane to the lumen (arrows). (c–e) An
oblonged subtype of spermatogonia (arrow) (c), preleptotene or resting spermatocytes (arrow) (d), and pachytene spermatocytes (arrow) (e) were
positive and particularly in this latter cytotype, the immunoreactive material appeared as a single roundish granule close to the nuclear membrane.
(f) Round spermatids contained intensely stained acrosomal/semilunar positive material with a perinuclear localization. An avidin-biotin im-
munohistochemical technique was used. Bars denote 20 μm.
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spermatids were positive to ARO (Fig. 2f), and the immunoreactive material, semilunar in shape, was localized in a perinuclear
position (probably corresponding to the acrosome complex).
3.3. 17β-Estradiol levels in tissue samples
OxA and OxB eﬀects on testicular 17β-estradiol secretion in vitro were assessed in adult male alpaca. Fig. 3 shows the results from
an in vitro experiment in which 1 nM of OxA alone or OxA and OX1R antagonist SB-408124, or OxB were added to alpaca testicular
slices. OxA signiﬁcantly decreased the basal level of 17β-estradiol secretion. Speciﬁcally, after 12 h, the 17β-estradiol level was lower
than that of the control (from 8.5 ± 0.3 to 5.4 ± 0.4 pg/g tissue, p < 0.01 versus control). Conversely the OX1R antagonist SB-
408124 seemed to nullify this eﬀect (from 5.4 ± 0.4 to 7.4 ± 1.5 pg/g tissue, p < 0.05 versus OxA). OxB did not produce any
eﬀects. The LH steroidogenic eﬀect (from 8.5 ± 0.3 to 10.8 ± 0.8 pg/g tissue, p < 0.01 versus control) guaranteed the tissue
vitality.
3.4. Expression of ARO in tissue samples
ARO activity was demonstrated in alpaca testis tissue slices incubated in the presence of T, OxA alone, OxA and the OX1R
antagonist, or OxB (Fig. 4). ARO activity was evaluated on the basis of 17β-estradiol production from exogenous T (35 μM) con-
version. In response to OxA, the ARO activity decreased (from 1.19 ± 0.04 to 0.59 ± 0.05 pg of 17β-estradiol/g tissue/h, p < 0.01
versus control). In contrast, the simultaneous presence of the OxA and OX1R antagonist, SB-408124, removed this eﬀect (from
0.59 ± 0.05 to 1.08 ± 0.1 pg of 17β-estradiol/g tissue/h, p < 0.01 versus OxA). Additionally, in this case, OxB did not produce any
eﬀects.
Fig. 3. Regulation of 17β-estradiol secretionin vitro in adult male alpaca tissue. Testicular slices were incubated with OxA alone, OxA and the OX1R
antagonist SB-408124, OxB, or LH (1 nM). The 17β-estradiol level in the medium was monitored after 12 h. Values were normalized per g of
incubated tissue. Data are expressed as mean ± S.D. (n 5 samples/group). *P < 0.05 **P < 0.01 vs. control, °P < 0.05 °°P < 0.01 vs. OxA
(ANOVA followed by Student test).
Fig. 4. Regulation of ARO activityin vitro in adult male alpaca tissue. Testicular slices were incubated with OxA alone, OxA and the OX1R antagonist
SB-408124, or OxB (1 nM). ARO activity evaluated as the conversion rate of testosterone to 17β-estradiol in the medium was monitored after 12 h.
Values are normalized as 17β-estradiol concentration produced per g of tissue and per h. Data are expressed as mean ± S.D. (n 5 samples/group).
*P < 0.05 **P < 0.01 vs. control, °, P < 0.05 °°P < 0.01 vs. OxA (ANOVA followed by Student test).
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4. Discussion
The goal of this research was to investigate the presence of ARO in the alpaca testis, and the possible eﬀects of OxA and OxB on
this enzyme, and the biosynthesis of E, expressed as 17β-estradiol. At ﬁrst, western blotting analysis was performed to demonstrate
the presence of ARO in the tissue extracts. Immunohistochemistry localized ARO both in the interstitial and tubular compartments of
the alpaca testis. The location, amount, and length of action of ARO are all vital for normal testicular development (Haverﬁeld et al.,
2011).
Although in many domestic species environmental factors such as temperature, humididy and photoperiod appear to aﬀect male
gonadal physiology (Albrizio et al., 2013), alpacas transferred in more temperate climates, became more fertile because, among
others, were given optimal nutrition at least along the major portion of the year (Fowler, 1998).
Previous studies performed by our research group demonstrated the presence and expression of the orexinergic complex in the
male gonad of the adult male alpaca (Liguori et al., 2012, 2017b). Particularly, OxA and OxB were seen in both the interstitial and
tubular compartments and their receptors were found only in the Leydig cells and developing spermatids (Liguori et al., 2012,
2017b). The immunohistochemical co-localization between the orexinergic complex and ARO in most testicular cytotypes can be
ascribed to a functional relationship between these substances in the tubular and interstitial compartments.
The regulation of ARO expression cannot be ignored in the testicular development. The detection of ARO-IR in the tubular
compartment of the testis during the diﬀerent phases of the reproductive cycle strongly suggests that ARO controls the proliferative
and meiotic phases of gametogenesis of mammals (Carreau et al., 2007). Thus, we can hypothesize a particular role played by ARO
alone or in combination with orexins during spermatogenesis. Alternatively, there could be a modulation of ARO activity by orexins.
Leydig cells immunoreactive to the orexin complex and ARO serve as important sites for activating the downstream signaling of
steroidogenesis. The balance between expression of ARO and sex hormone titer is quite interesting. Previous ﬁndings demonstrated
the eﬀects of OxA on steroidogenesis in the alpaca testis. A signiﬁcant increase of T synthesis was observed after the addition of OxA
in testis slices. The countereﬀect was discovered when the steroidogenic compound Müllerian Inhibiting Substance (MIS) was added
to OxA, and vice versa. The overlying principle is most probably the OxA-induced decrease of MIS expression (Liguori et al., 2012).
Hence, MIS no longer inhibited T synthesis and an elevated T level was detected. These ﬁndings in the alpaca testis provide clear
evidence that OxA truly plays an antagonistic role in MIS-inhibited T synthesis. These data conﬁrm the ﬁndings from a previous study
involving rat testis (Assisi et al., 2012). The unique ﬁnding regarding the OxB eﬀect on steroidogenesis was obtained from rat testis,
and suggested that OxB had no discernable inﬂuence on steroidogenesis. (Liguori et al., 2017a). To elucidate and deepen our previous
data, we presently investigated the eﬀects of OxA and OxB on E biosynthesis expressed as 17β- estradiol, and the consequent eﬀects
on ARO modulation. ARO is considered the principal source of E in the mammalian testis. According to Raven et al. (2006), ARO
inhibition is associated with lowered E levels and subsequently elevated levels of gonadotropins and T, through the E-sensitive male
hypothalamus-pituitary-gonadal axis, which potentially stimulates sperm production. In the assessment of orexins on testicular E
secretion, OxA decreased the level of E, particularly 17β-estradiol. This eﬀect vanished upon the addition on the OX1R antagonist,
SB-408124. On the contrary, OxB did not aﬀect the basal E secretion. This OxA-mediated down-regulation of E secretion may be
ascribed to ARO inhibition by exogenous OxA. Concerning the OxA-induced down-regulation of E, the lowered E level may be caused
by reduced ARO activity, perhaps due to the inhibition of its genetic expression. This result was conﬁrmed by the addition of SB-
408124, the speciﬁc antagonist for OX1R (the speciﬁc receptor for OxA). This addition signiﬁcantly aborgated the inhibitory eﬀect of
OxA, suggesting that OxA may act via OX1R. In this regard, a study revealed that postmenopausal women not on E replacement
therapy displayed signiﬁcantly higher plasma OxA levels and signiﬁcantly lower E levels (El-Sedeek et al., 2010). Moreover, the
injection of orexins signiﬁcantly decreased the mean hypothalamic ARO mRNA level in androgenized female rats compared to
androgenized control group (Salimi et al., 2016). In addition, the inﬂuence of OxA was described in the porcine uterus ster-
oidogenesis during pregnancy (Kiezun et al., 2017).
Taken together, the ﬁndings imply that OxA may indirectly regulate ARO expression causing a decrease in E levels and conse-
quently stimulate T production. The steroidogenic eﬀect of OxA and its indirect modulation on ARO activity led us to hypothesize a
possible role of this peptide as a therapeutic target for pathological conditions associated with steroidogenic alterations.
5. Conclusions
In summary, although the role of the orexinergic complex in testicular development and function is still regarded as being
nonessential, evidence that questions this assumption is accumulating. Concerning the inﬂuence of orexins on steroidogenesis, OxA
induced T secretion by interacting with OX1R, presumably by reducing the gene expression of the innate T inhibitor MIS, thereby
increasing T synthesis (Liguori et al., 2012). On the other hand, OxA was also involved in down-regulating E secretion. This was most
likely due to the diminution of ARO activity, which further disabled the conversion of T to E and consequently increased the OxA-
mediated synthesis of T. OxB did not aﬀect steroidogenesis. Orexin-induced steroidogenesis is a poorly-understood phenomenon.
Increased knowledge could provide a basis for developing therapeutic treatments for both animals and humans.
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